Last reviewed · How we verify
Real time enoxaparin dose adjustment
At a glance
| Generic name | Real time enoxaparin dose adjustment |
|---|---|
| Sponsor | University of Utah |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Splenic Embolization
Key clinical trials
- Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma (PHASE2)
- Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype (PHASE1, PHASE2)
- Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose (EARLY_PHASE1)
- Enoxaparin Metabolism in Reconstructive Surgery Patients (PHASE2)
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |